RxDoctor Payments Data

Joseph Berger, DO

Family Medicine · Fairfield, TXNPI 1508859596

Payments from drug & device makers

$1,061in general payments, 2019–2025

Across 32 payments — averaging $33.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$365
  • Johnson & Johnson$118
  • Intersect ENT, Inc.$115
  • Astellas Pharma US Inc$97
  • Boehringer Ingelheim$91
  • Exact Sciences$47
  • plus $228 from 7 others

What the payments were for

  • Food & beverage$1,061100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,061 in reported general payments places this provider in the 60th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$13,902
Medicare patients
94
Services billed
102

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
FarxigaDapagliflozin Propanediol40$30,052
MounjaroTirzepatide27$28,146
RybelsusSemaglutide16$23,457
TrulicityDulaglutide20$22,342
JardianceEmpagliflozin20$15,945
OzempicSemaglutide14$12,853
ShingrixVaricella-Zoster Ge/As01b/Pf54$11,073
ArexvyRsvpref3 Antigen/As01e/Pf34$9,583
AbrysvoRsv Vacc, Pref A And Pref B/Pf30$8,771
Breo ElliptaFluticasone/Vilanterol14$7,190
BelsomraSuvorexant12$5,124
Fluticasone-SalmeterolFluticasone Propion/Salmeterol20$4,277
Potassium Chloride137$3,823
Atorvastatin Calcium454$3,518
Metoprolol Succinate215$3,205

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$34$50,48847 claims
Novo NordiskRybelsus, Ozempic$365$36,31030 claims
GSKShingrix, Arexvy, Breo Ellipta$17$27,845102 claims
Boehringer IngelheimJardiance$91$15,94520 claims
PfizerAbrysvo$43$8,77130 claims
AbbVieSynthroid$42$1,13714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Fairfield

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →